Why Turning Point Brands may be a better investment than Altria

Aug.30.2022
Why Turning Point Brands may be a better investment than Altria
Turning Point Brands stock (TPB) is currently a better choice due to lower valuation compared to Altria (MO).

Compared to tobacco giant Altria (NYSE: MO), smaller tobacco company Turning Point Brands (NYSE: TPB) is currently a better choice due to its lower relative valuation of 0.8x compared to Altria's 3.2x tracking revenue. This valuation gap is primarily due to Altria's superior earnings capabilities.


Looking at stock returns, despite a 3% decline year-to-date, Altria has outperformed Turning Point Brands, which has fallen 36%, as well as the broader S&P 500 index, which has dropped 13%. However, there is more to consider and in the section below, we will discuss why we believe TPB stock will offer better returns than MO stock over the next three years. We compared a range of factors, such as historical revenue growth, return, and valuation multiples, in our interactive dashboard analysis of Altria versus Turning Point Brands: which stock is the better choice? A summary of the partial analysis is provided below.


1. Turning point brands experience decent revenue growth.


Two companies have both released their sales growth in the past twelve months. Despite this, Turning Point Brands' revenue growth of 5.0% is higher than Altria's 0.2%. Even when we look at a longer time frame, Turning Point Brands has performed well, with its sales growing at an average annual rate of 10.2% to $445.5 million in 2021, up from $332.7 million in 2018, while Altria's sales have grown by 0.9% to $26 billion currently, up from $25.4 billion in 2018.


Altria sells tobacco products in the US market and generates revenue from the sale of both smoking and smokeless products. However, their revenue growth was impacted during the pandemic due to supply disruptions. Last year, Altria sold its wine business for $1.2 billion and has since focused more on smoking and smokeless products. For a more in-depth understanding of the company's sales performance, our Altria revenue dashboard is available.


Turning Point Brands sells vapor products, chewing tobacco, rolling papers, and cigar wraps, among other items. Its Zig-Zag division, which includes rolling papers, cigar wraps, and smoking accessories, has been driving the company's sales growth in recent years. However, due to regulatory changes, Turning Point Brands' vapor business has recently declined, particularly after the implementation of a new rule in the Prevent All Cigarette Trafficking (PACT) Act at the end of last year. Following recent regulatory changes, it has become challenging to mail anything related to vapor to either businesses or consumers.


Sales for Turning Point Brands' NewGen division, which includes vapor products, decreased significantly by 41% in the first half of this year, comprising only 23% of its total net sales. In comparison, last year's sales for the same period accounted for 35%. Conversely, the company's other divisions, Zig-Zag and Stoker, have consistently performed well, and this trend is expected to continue in the coming years.


Looking towards the future, Turning Point Brands is expected to experience faster revenue growth over the next three years than Altria. The table below summarizes our revenue expectations for both companies over the next three years, based on Trefis machine learning analysis. Turning Point Brands is projected to have a compound annual growth rate of 15.2%, while Altria's compound annual growth rate is only expected to be 1.6%.


Please note that when predicting future income, we have different methods for companies that have been negatively impacted by Covid compared to those that have not been affected or have had a positive impact. For companies negatively affected by Covid, we consider the quarterly revenue recovery trajectory to predict a return to pre-Covid income levels. After the recovery point, we apply the average annual growth rate observed in the three years before Covid to simulate a return to normalcy. For companies that have experienced positive revenue growth during Covid, we consider the average annual growth before Covid, with some weight placed on growth during Covid and the past 12 months.


Altria earns more money" in standard journalistic English.


In the past 12 months, Altria's operating profit margin was 17.6%, surpassing Turning Point Brands' margin of 12.6%. This is a significant improvement from pre-pandemic 2019 figures, which stood at 3.1% and 4.5% respectively. Additionally, Altria's free cash flow profit margin of 32.6% is much better than Turning Point Brands' 11.1%.


Our dashboard for Altria's revenue and Turning Point Brand's revenue has more detailed information. In terms of financial risk, Altria has a much lower debt-to-equity ratio of 34% compared to Turning Point Brand's 94%. Additionally, Altria's cash-to-asset ratio of 13% is lower than the latter's 20%, indicating that Altria has a better debt position, while Turning Point Brands has more cash reserves.


万物之网" can be translated to "The Network of All Things" in standard journalistic English.


We can see that Turning Point Brands has exhibited stronger revenue growth, has more cash reserves, and is relatively undervalued. On the other hand, Altria has a better debt situation and higher profits. Looking ahead, based on the P/S ratio and due to the high volatility of the P/E and P/EBIT ratios, we believe that Turning Point Brands is the better choice between the two.


The table below summarizes our revenue and return expectations for Altria and Turning Point Brands over the next three years, indicating that the expected return for Turning Point Brands during this period is 58%, while the expected return for Altria's stock is only 5%. This means that according to Trefis machine learning analysis, investors would be better off purchasing TPB instead of MO, and this analysis also provides more details on how we arrived at these figures.


While TPB's stock performance may be better than MO's, the Covid-19 crisis has caused many pricing discontinuities, which can provide attractive trading opportunities. For example, you would be surprised at how counterintuitive the stock valuations of Philip Morris and Coca-Cola are.


Statement


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS, and we cannot confirm the authenticity or accuracy of its contents. The compilation of this article is solely for the purpose of industry exchange and research.


Due to limitations in our translation abilities, the translated article may not fully convey the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS maintains full alignment with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, and foreign-related positions and statements.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
Philip Morris International’s IQOS has entered the Kantar BrandZ Top 100 Most Valuable Global Brands for the first time, ranking No. 74 with a brand value of $36.634 billion and becoming one of only three newcomers to the 2026 ranking. Kantar said the combined value of the Global Top 100 reached $13.1 trillion, up 22% year on year, while the threshold for entry rose to a record high. PMI says IQOS has more than 35 million users worldwide and surpassed $10 billion in annual net revenues within a decade of launch.
Sep.03
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Philip Morris International (PMI) has launched ZYN Melts in the UK, introducing a fully dissolvable oral nicotine tablet format alongside the brand's existing nicotine pouches. The range includes Cool Mint and Peppermint, each offered at 1mg and 2mg of nicotine per tablet, creating four SKUs. Each can contains 20 tablets and is priced at £6.50 in the UK. Unlike ZYN nicotine pouches, Melts are placed between the upper lip and gum and dissolve completely during use.
News
Sep.29 by 2Firsts Perspectives
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Technology reported FY2026 revenue of about $96 million, down 24.7% year over year, as U.S. cannabis-vapor hardware and European e-cigarette sales declined by $17.4 million and $12.7 million, respectively. Fourth-quarter revenue rose 32.5% to $26.7 million, while quarterly gross margin fell to 6.3%. For FY2027, the company is prioritizing Malaysia manufacturing and vapor ODM while continuing to develop nicotine pouches, IKE Tech age-verification technology and G-Mesh licensing. Ispire has not separately disclosed the revenue or profit contribution of those newer businesses.
Regulations
Sep.17 by 2Firsts Perspectives
U.S. Expands Illicit Vape Enforcement as ATF Brings PACT Act Powers Into Trade Fraud Task Force
U.S. Expands Illicit Vape Enforcement as ATF Brings PACT Act Powers Into Trade Fraud Task Force
The U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives said on September 23 that it has joined the interagency Trade Fraud Task Force to strengthen enforcement against illegal, misdeclared and smuggled vape and tobacco products. ATF will bring its authority under the Prevent All Cigarette Trafficking Act into the task force, including registration, reporting, shipping and record-inspection requirements covering interstate sales of electronic nicotine delivery systems. ATF said the move will strengthen its ability to trace illicit products from U.S. points of entry through domestic trafficking and distribution networks.
News
Sep.28 by 2Firsts Perspectives
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
The UK Insolvency Service said YSK Enterprises imported large quantities of vapes from China in 2023, with a shipment addressed to the company declared as medical nebulizers before Border Force found 352,688 vaping products. HMRC calculated nearly £15 million ($20.3 million) in unpaid VAT and customs duty, alongside about £437,000 in corporation tax. Two directors were disqualified for nine years. The case predates the UK's Vaping Products Duty, which will introduce vape-specific excise and duty-stamp requirements from October 2026.
Regulations
Sep.11
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands reaffirmed its FY26 guidance in its October 8 pre-close trading update, forecasting double-digit net revenue growth in next-generation products and share gains across heated tobacco, vape and modern oral. Tobacco net revenue is expected to grow at a low-single-digit rate, marking a sixth consecutive year of growth. The company has completed its £1.45 billion FY26 share repurchase and announced a £1.5 billion buyback for FY27. Group adjusted operating profit is expected to increase 3% to 5%, while free cash flow is forecast to exceed £2.2 billion.
Oct.09